-
PublishedFebruary 1, 2023
Sen. Collins spearheads efforts to fund Alzheimer’s research
A bipartisan group of senators is proposing to boost funding for research and prevention through 2035.
-
PublishedSeptember 28, 2022
Gov. Mills launches program to give grants up to $2,000 to family caregivers
The $5.1 million program is for family caregivers of patients with disabilities, such as Alzheimer's and dementia, who are being cared for at home.
-
PublishedSeptember 17, 2022
Photos: 2022 Walk to End Alzheimer’s
Hundreds of people took part in Saturday morning's annual walk in Lewiston.
-
PublishedJuly 13, 2021
Medicare evaluating coverage for $56,000 Alzheimer’s drug
Although pricey drugs are now fairly commonplace, the recent approval of Aduhelm prompted an unusually intense backlash.
-
PublishedJuly 9, 2021
FDA chief calls for investigation into review of controversial new Alzheimer’s drug
It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.
-
PublishedJuly 8, 2021
FDA reverses itself under pressure, moves to limit use of new Alzheimer’s drug
The Food and Drug Administration says the change is intended to address confusion among physicians and patients about who should get Aduhelm, which has faced an intense public backlash since its approval last month.
-
PublishedJune 20, 2021
Controversial new Alzheimer’s drug gives patients in Maine hope
The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.
-
PublishedJune 7, 2021
FDA approves new drug for Alzheimer’s that experts doubt will work
The decision is sure to spark disagreements among doctors, medical researchers and patient groups, and have far-reaching implications for the standards used to evaluate experimental therapies.
-
PublishedMay 22, 2020
Maine CDC reports 71 new coronavirus cases as outbreak hits Cape Elizabeth memory care home
The additional cases and 2 deaths come at a time when the Mills administration is relaxing restrictions on businesses to begin reviving Maine's economy.
-
PublishedSeptember 4, 2019
Alzheimer’s disease threatens an aging Maine
With the number of Mainers with Alzheimer's rising rapidly, research at The Jackson Lab and beyond is crucial to slowing its impact on families and taxpayers.
- 1
- 2
- Next Page →
